• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Flexible Sensors Detect Heavy Metals in Sweat

      Flexible Sensors Detect Heavy Metals in Sweat

      Nanopore Sensor to Study Protein Aggregation in Neurodegeneration

      Nanopore Sensor to Study Protein Aggregation in Neurodegeneration

      Biobots Use Optogenetic Muscle Actuators for Movement

      Biobots Use Optogenetic Muscle Actuators for Movement

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

    • Radiology
      Ultrasound Tornado Rapidly Disrupts Blood Clots

      Ultrasound Tornado Rapidly Disrupts Blood Clots

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Fluorescence Imaging System Illuminates Tumor Depth

      Fluorescence Imaging System Illuminates Tumor Depth

      Soft Robot Grows Like a Plant to Travel Through Tight Spaces

      Soft Robot Grows Like a Plant to Travel Through Tight Spaces

    • Cardiology
      Belt Monitors Heart Failure Patients

      Belt Monitors Heart Failure Patients

      Camera Measures Blood Pressure with Quick Look

      Camera Measures Blood Pressure with Quick Look

      Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

      Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

    • Surgery
      Microneedle Bandage for Hemostatic Control

      Microneedle Bandage for Hemostatic Control

      Biobots Use Optogenetic Muscle Actuators for Movement

      Biobots Use Optogenetic Muscle Actuators for Movement

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

    • Nanomedicine
      Extra Hot Nanoparticles for Cancer Therapy

      Extra Hot Nanoparticles for Cancer Therapy

      Making Tumors Tastier for the Immune System

      Making Tumors Tastier for the Immune System

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Magnetic Bacteria Target Tumors

      Magnetic Bacteria Target Tumors

    • Military Medicine
      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fabric Makes Electricity from Movement to Power Wearables

      Fabric Makes Electricity from Movement to Power Wearables

      Wearable Uses Microneedles to Track Metabolism

      Wearable Uses Microneedles to Track Metabolism

    • Rehab
      Smart Walking Stick for Visually Impaired People

      Smart Walking Stick for Visually Impaired People

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Implanted Magnets for Prosthetic Control

      Implanted Magnets for Prosthetic Control

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

Global Cancer Immunotherapy Market and Clinical Trials Outlook 2022

January 11th, 2018 Kuick Research Releases

For Report Sample Contact: neeraj@kuickresearch.com

 

Report Weblink: https://www.kuickresearch.com/report-global-cancer-immunotherapy-market-and-clinical-trials-outlook-2022.php

 

Table of Contents

 

1. Immunotherapy: Mending Cancer Regimens

  1.1 Preface to Cancer Immunotherapy

  1.2 Evolution of Cancer Immunotherapy

2. Categorization of Cancer Immunotherapy

  2.1 Specific Cancer Immunotherapy

    2.1.1 Cancer Vaccines

    2.1.2 Monoclonal Antibodies

  2.2 Non-Specific Cancer Immunotherapy

    2.2.1 Adoptive Cell Transfer Immunotherapy

    2.2.2 Immune Checkpoint Inhibitors

3. Fundamentals of Cancer Vaccines

  3.1 Prologue of Cancer Vaccines

  3.2 Cancer Vaccines in Immunotherapy

  3.3 Commercial Aspects of Cancer Vaccines

4. New Era of Monoclonal Antibodies

  4.1 Rudiments of Monoclonal Antibodies

  4.2 Advents of Monoclonal Antibodies

  4.3 Commercial Aspects of Monoclonal Antibodies

5. Trails of T-Cell Therapies

  5.1 Adoptive Cell Transfer Technology

  5.2 Strategies of Adoptive Cell Transfer

  5.3 Commercial Aspects of Adoptive Cell Therapy

6. Aspects of Immune Checkpoint Inhibitors

  6.1 Prelude to Immune Checkpoint Inhibitors

  6.2 Implications of Immunecheck Point Inhibitors

  6.3 Commercial Aspects of Immune Checkpoint Inhibitors

7. Immunomodulators in Cancer Immunotherapy

  7.1 Perspective of Immunomodulators

  7.2 Clinical Aspects of Immunomodulators

  7.3 Commercial Aspects of Immunomodulators

8. Oncolytic Viral Immunotherapy

  8.1 Concept to Oncolytic Viruses

  8.2 Potential Approaches of Oncolytic Viruses

  8.3 Commercial Aspects of Oncolytic Viruses

9. Cytokines in Cancer Immunotherapy

  9.1 Fundamentals of Cytokines

  9.2 Classification of Cytokines

  9.3 Commercial Aspects of Cytokines

10. Interferons in Immunotherapy

  10.1 Potentials of Interferons

  10.2 Classification of Interferons

  10.3 Clinical Applications of Interferons

11. Interleukins in Immunotherapy

  11.1 Potentials of Interleukins

  11.2 Clinical Applications of Interleukins

12. GM-CSF in Immunotherapy

  12.1 Potentials of GM-CSF

  12.2 Clinical Applications of GM-CSF

13. Global Economic Evaluations

  13.1 Economic Aspects of Cancer Immunotherapy

  13.2 Cancer Immunotherapy Cost by Product

14. Market Aspects of Cancer Immunotherapy

  14.1 Current Market Trends

  14.2 Cancer Immunotherapy Pipeline Overview

15. Global Cancer Immunotherapy Market Dynamics

  15.1 Favorable Market Parameters

  15.2 Commercialization Challenges

16. Marketed Cancer Cell Therapies Drugs

  16.1 Sipuleucel-T (Provengeandreg;)

  16.2 T-Lymphocyte Cell Therapy(Immuncell-LCandreg;)

17. Marketed Cancer Cytokines Drugs

  17.1 Aldesleukin (Proleukinandreg;)

  17.2 Denileukin Diftitox (ONTAKandreg;)

  17.3 Interferon Alpha (Multiferonandreg;)

  17.4 Interferon Alpha-2a (Roferon-Aandreg;)

  17.5 Interferon Alpha-2a (Veldonaandreg;)

  17.6 Interferon Alpha-2a Biosimilar(Inferonandtrade;/Inmutagandtrade;)

  17.7 Interferon Alpha-2b(Intronandreg; A)

  17.8 Interferon Alpha-2b Biosimilar(Bioferonandtrade;)

  17.9 Interferon Alpha-2b Biosimilar (Intalfaandreg;)

  17.10 Interferon Alpha-2b Biosimilar

  17.11 Interferon-Alpha-n3 (Alferon Nandreg;)

  17.12 Interferon-Beta-1b (Feronandreg;)

  17.13 Interferon-Gamma (Ogammaandreg;)

  17.14 Interleukin-2 Biosimilar (Ilcass)

  17.15 Teceleukin (Imunaceandtrade;)

18. Marketed Cancer Vaccines

  18.1 Bladder Cancer Vaccine (PACISandreg;)

  18.2 Bladder Cancer Vaccine

  18.3 BV NSCLC 001

  18.4 Dendritic Cell Vaccine (CreaVax-HCCandreg;, CreaVax-PCandreg; and CreaVax-RCCandreg;)

  18.5 Human Papillomavirus Vaccine Quadrivalent (Gardasilandreg;/Silgardandreg;)

  18.6 Human Papillomavirus Vaccine Recombinant Bivalent (Cervarixandreg;)

  18.7 Melanoma Vaccine (MVaxandreg;)

  18.8 Melanoma Vaccine (Melacineandreg;)

  18.9 Racotumomab (Vaxiraandreg;)

  18.10 Sipuleucel-T (Provengeandreg;)

  18.11 Tertomotide (LucaVax)

  18.12 Vitespen (Oncophageandreg;)

19. Marketed Cancer Monoclonal Antibodies

  19.1 Bevacizumab

  19.2 Trastuzumab Emtansine

  19.3 Trastuzumab Subcutaneous

  19.4 Brentuximab Vedotin

  19.5 Catumaxomab

  19.6 Ipilimumab

  19.7 Nivolumab

  19.8 Pembrolizumab

  19.9 Pertuzumab

  19.10 Rituximab

  19.11 Trastuzumab

20. Global Cancer Immunotherapy Market Future Prospects

21. Competitive Landscape

  21.1 Abbvie

  21.2 Advaxis

  21.3 Altor BioScience

  21.4 Amgen

  21.5 Biogen Idec

  21.6 Biogenomics

  21.7 Celldex Therapeutics

  21.8 Dendreon Corporation

  21.9 Eli Lilly

  21.10 Expression Genetics

  21.11 Galena Biopharma

  21.12 Genmab

  21.13 Gilead Sciences

  21.14 GlaxoSmithKline

  21.15 ImmunoCellular Therapeutics

  21.16 ImmunoGen

  21.17 Inovio Pharmaceuticals

  21.18 IRX Therapeutics

  21.19 Merck

  21.20 NeoStem Oncology

  21.21 NewLink Genetics

  21.22 Northwest Biotherapeutics

  21.23 Novartis

  21.24 Peregrine Pharmaceuticals

  21.25 Pfizer

  21.26 Philogen

  21.27 Regulon

  21.28 Roche

  21.29 Seattle Genetics

  21.30 ZymoGenetics

 

Figure 1-1: Evolutionary Trails of Cancer Immunotherapy
Figure 1-2: Layout of Necessity of Cancer Immunotherapies for Cancer Treatment
Figure 1-3: Potential Benefits of Cancer Immunotherapies
Figure 2-1:  Classification of Cancer Immunotherapies
Figure 2-2: Categorization of Specific Immunotherapy
Figure 2-3: Non-Specific Cancer Immunotherapies
Figure 3-1: Categorization and Function of Cancer Vaccines
Figure 3-2: Mechanism of the Cancer Vaccine towards Tumor Eradication
Figure 3-3: Global Cancer Vaccines Market (US$ Billion), 2016-2022
Figure 4-1: Process of Manufacturing of Monoclonal Antibody
Figure 4-2: Principles of Monoclonal Antibodies
Figure 4-3: Evolution of Monoclonal Antibody over Generations
Figure 4-4: Classification of Monoclonal Antibodies
Figure 4-5: Representation of Mechanism of Alemtuzumab
Figure 4-6: Representation of Mechanism of Ibritumomab Tiuxetan
Figure 4-7: Representation of Mechanism of Blinatumomab
Figure 4-8: Global Market for Cancer Monoclonal Antibodies (US$ Billion), 2016-2022
Figure 5-1: Benefit of Adoptive Cell Transfer Immunotherapy
Figure 5-2: Systematic Representation of Adoptive T-Cell Therapies
Figure 5-3: Three Adoptive Cell Transfer Strategies for Cancer Immunotherapy
Figure 5-4: Tumor-Infiltrating Lymphocytes in Adoptive Cell Transfer
Figure 5-5: Mechanism of CAR Modified T-Cells
Figure 5-6: Genetically Engineered TCR for Cancer Immunotherapy
Figure 5-7: Global Predictive Market of CAR T-Cell Therapeutics (US$ Million), 2016-2022
Figure 6-1: Benefits of Immune Checkpoint Inhibitors
Figure 6-2: Implication of Adaptive Immune Resistance Mechanism
Figure 6-3: Mechanism of Ipilimumab
Figure 6-4: Layout of Mechanism of Nivolumab
Figure 6-5: Mechanism of Pembrolizumab
Figure 6-6: Global –  Immune Check Point Inhibitors Market (US$ Billion), 2016-2022
Figure 7-1: Functions of Immunomodulators
Figure 7-2: Benefits of Immunomodulators
Figure 7-3: Layout of the Challenges of Immunomodulators
Figure 7-4: Properties of Thalidomide
Figure 7-5: Mechanism of Lenalidomide In Vivo
Figure 7-6: Mechanism of Lenalidomide in Vitro
Figure 7-7: Mechanism of Pomalidomide
Figure 7-8: The Global Market for Immunomodulators for All Indications (US$ Billion), 2016-2022
Figure 8-1: Demonstration of Categorization of Oncolytic Viruses
Figure 8-2: Potential Advantages of Oncolytic Viruses over Conventional Therapies
Figure 8-3: The Predicted Market Share of Oncolytic Viral Therapies (US$ Million), 2016-2022
Figure 9-1: Layout of Functions Performed by Cytokine
Figure 9-2: Benefits of Cytokines in Cancer Immunotherapy
Figure 9-3: Classification of Cytokine Receptor Family
Figure 9-4: Percentage Share of the Cancer Immunotherapies by the Technology
Figure 10-1: Layout of Functions of Interferon
Figure 10-2: Classification of Interferons on the Basis of Types of Genes
Figure 10-3: General Mechanism of Interferons
Figure 10-4: Mechanism of Interferon Alfa-n3
Figure 10-5: Aspects of Peginterferon Alfa-2a
Figure 10-6: Applications of Interferon Beta 1a
Figure 10-7: Potentials of Interferon Alfa-2b
Figure 11-1: Functions of Interleukin
Figure 11-2: Potentials of Interleukins in Cancer Immunotherapy
Figure 11-3:  Clinical Potentials of Proleukin
Figure 11-4: Clinical Potentials of Denileukin Diftitox
Figure 12-1: Potential Applications of GM-CSF
Figure 12-2: Mechanism of Sargramostim
Figure 13-1: Expected Cancer Treatment Cost (US$ Billion), 2016-2022
Figure 13-2: Comparative Analysis of Available Cancer Treatments
Figure 13-3: Major Approved Immunotherapeutic Drugs
Figure 13-4: Annual per Patient Drug Expenditure of Immunotherapy
Figure 14-1: Global Cancer Immunotherapeutic Market (US$ Billion), 2016-2022
Figure 14-2: Global – Cancer Vaccine Clinical Pipeline by Phase (%), 2017 – 2022
Figure 14-3: Global – Cancer Vaccine Clinical Pipeline by Phase (Number), 2017 -2022
Figure 14-4: Global – Cancer Vaccine Suspended/Discontinued in Clinical Pipeline by Phase (%), 2017 -2022
Figure 14-5: Global – Cancer Vaccine Suspended/Discontinued in Clinical Pipeline by Phase (Number), 2017 -2022
Figure 14-6: Global – Cancer Monoclonal Antibodies Clinical Pipeline by Phase (%), 2017 -2022
Figure 14-7: Global – Cancer Monoclonal Antibodies Clinical Pipeline by Phase (Number), 2017 -2022
Figure 14-8: Global – Cancer Cell Therapies Clinical Pipeline by Phase (%), 2017 -2022
Figure 14-9: Global – Cancer Cell Therapies Clinical Pipeline by Phase (Number), 2017 -2022
Figure 14-10: Global – Cancer Cell Therapies Suspended/Discontinued in Clinical Pipeline by Phase (%), 2017 -2022
Figure 14-11: Global – Cancer Cell Therapies Suspended/Discontinued in Clinical Pipeline by Phase (Number), 2017 – 2022
Figure 14-12: Global – Cancer Immunomodulators Clinical Pipeline by Phase (%), 2017 – 2022
Figure 14-13: Global – Cancer Immunomodulators Clinical Pipeline By Phase (Number), 2017 – 2022
Figure 15-1: Favorable Cancer Immunotherapy Market Parameters
Figure 15-2: Cancer Immunotherapy Commercialization Challenges
Figure 21-1: Advaxis Clinical Pipeline
Figure 21-2: Celldex Therapeutics Clinical Pipeline
Figure 21-3: Expression Genetics Clinical Pipeline
Figure 21-4: Galena Biopharma Clinical Pipeline
Figure 21-5: ImmunoCellular Therapeutics Clinical Pipeline
Figure 21-6: ImmunoGen Clinical Pipeline
Figure 21-7: Inovio Pharmaceuticals Clinical Pipeline
Figure 21-8: NewLink Genetics Corporation  Clinical Pipeline
Figure 21-9: Northwest Biotherapeutics Clinical Pipeline
Figure 21-10: Peregrine Pharmaceuticals Clinical Pipeline
Figure 21-11: Philogen Clinical Pipeline
Figure 21-12: Seattle Genetics Clinical Pipeline

 

 

 

Table 4-1: Different Monoclonal Antibodies Used in Cancer Immunotherapy
Table 6-1: Illustration of Some Important Checkpoint Inhibitors
Table 9-1: Few Important Immunocytokines under Clinical Development
Table 9-2: Some Pharmacologically Important Cytokines Used in Cancer Immunotherapies
Table 14-1: Few Commercially Important PD-1 Drugs

 

Sign up and submit a press release

Sponsored
C-mo Medical Solutions extends seed investment round to €4.8 million to transform cough monitoring

C-mo Medical Solutions extends seed investment round to €4.8 million to transform cough monitoring

New Clarius Power Fan HD3 Delivers a First for Handheld Ultrasound: Continuous Scanning

New Clarius Power Fan HD3 Delivers a First for Handheld Ultrasound: Continuous Scanning

Fluidx Unveils New Embolic for Neurovascular Use

Fluidx Unveils New Embolic for Neurovascular Use

Annalise.ai and Nuance Communications (a Microsoft Company) Announce Key Partnership to Improve Patient Outcomes with Workflow-Integrated AI

Annalise.ai and Nuance Communications (a Microsoft Company) Announce Key Partnership to Improve Patient Outcomes with Workflow-Integrated AI

PT Genie Unveils New Brand Identity Reflecting Company’s Transformation and Focus on the Global Future of AI and Machine Learning in Digital Healthcare

interviews & reviews
Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Exciting Medtech at the Healthcareᐩ Expo Taiwan

Exciting Medtech at the Healthcareᐩ Expo Taiwan

Medgadget Visits Healthcareᐩ Expo Taiwan

Medgadget Visits Healthcareᐩ Expo Taiwan

Diabetes Management Tech for Type II patients: Interview with Jeffrey Brewer, CEO of Bigfoot Biomedical

Diabetes Management Tech for Type II patients: Interview with Jeffrey Brewer, CEO of Bigfoot Biomedical

Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

In-Office Pediatric Ear Tube Procedures: Interview with Preceptis Medical's Greg Mielke

In-Office Pediatric Ear Tube Procedures: Interview with Preceptis Medical's Greg Mielke

Symani Microsurgical Robotic System: Interview with Mark Toland, CEO of Medical Microinstruments

Symani Microsurgical Robotic System: Interview with Mark Toland, CEO of Medical Microinstruments

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
Posting....
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email